Results 271 to 280 of about 134,239 (340)

Effectiveness and Acceptability of A Community-Based Comprehensive Smoking Cessation Intervention Incorporating Traditional Chinese Medicine Therapy - Qingdao City, Shandong Province, China, December 2023-December 2024. [PDF]

China CDC Wkly
Yin Y, Wang Y, Yang J, Xu H, Ma K, Gong H, Qi F, Nan Y.   +7 more
europepmc   +1 more source

Development of a novel risk score reflecting the relative harm potential of synthetic cannabinoids based on prevalence estimates, well‐documented intoxication cases and basic pharmacological data

Addiction, EarlyView.
Abstract Background and aims While the health hazards of synthetic cannabinoid receptor agonists (SCRAs) are often approximated using in vitro pharmacological parameters as surrogate, this approach fails to consider pharmacokinetic and pharmacodynamic complexity.
Michaela J. Sommer, Katharina Elisabeth Grafinger, Maren Hermanns‐Clausen, Volker Auwärter   +3 more
wiley   +1 more source

Lottery incentives for smoking cessation at the workplace: a cluster randomized trial. [PDF]

BMC Public Health
van der Swaluw K, Roordink E, van der Vliet N, Schipper M, Hiemstra M, Zeelenberg M, Proper K, Lambooij M.   +7 more
europepmc   +1 more source

Appetitive responses toward smoking‐related stimuli in abstinence‐motivated, non‐deprived individuals with chronic tobacco dependence: A multi‐methodological investigation

Addiction, EarlyView.
Abstract Background and aims Appetitive responses, such as approach biases, are thought to play a crucial role in smoking. This study aimed to compare responses toward smoking‐related stimuli with responses in control conditions (e.g. non‐approach or neutral stimuli) using a multi‐method approach. By examining associations between response measures and
Franziska Motka, Haoye Tan, Seth M. Levine, Sabine Vollstädt‐Klein, Sarah K. Danböck, Katja Bertsch, Markus H. Winkler, Charlotte E. Wittekind   +7 more
wiley   +1 more source

Exploring Scottish addiction services: provider-based stigma, addiction aetiology beliefs, treatment bias, and burnout among addiction treatment providers. [PDF]

Subst Abuse Treat Prev Policy
Ciesluk B, Inglis G, Parke A, Troup LJ.
europepmc   +1 more source

Long term effects of Vernonia cinerea on continuous abstinence rate of smoking cessation: a subgroup analysis of meta-analysis

Sittichai Khamsai, Pawarisa PHADUNGWONG, Kittisak Sawanyawisuth   +2 more
openalex   +1 more source

Detecting cannabis use reduction through biochemical verification of urinary cannabinoids: An aggregated analysis of cannabis use disorder treatment trials examining average reductions and individual cut‐points

Addiction, EarlyView.
Abstract Background and aims Currently, there is no data‐driven cannabis reduction metric using biochemical verification, which represents a significant gap in cannabis harm reduction research, treatment and policy. Using aggregated data from 7 cannabis use disorder treatment trials, the aims of this analysis were to 1) determine if decreases in self ...
Erin A. McClure, Brian Neelon, Rachel L. Tomko, Ashley Dowd, Kevin M. Gray, Aimee L. McRae‐Clark, Nathaniel Baker   +6 more
wiley   +1 more source

Exercise participation and health promotion in active seniors in aging societies: keys to successful aging. [PDF]

Front Public Health
Choi SJ, Zheng F, Lee SM.
europepmc   +1 more source

Endocannabinoid system gene expression in mesocorticolimbic brain regions of individuals with alcohol use disorder: A descriptive study

Addiction, EarlyView.
Abstract Aims To describe differences in the expression of genes encoding cannabinoid receptors (CNR1, CNR2), the associated receptor GRP55 and the enzymes fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MGLL) between individuals with alcohol use disorder (AUD) and controls in key mesocorticolimbic brain regions.
María Salud García‐Gutiérrez, Abraham Bailén Torregrosa, Francisco Navarrete, Auxiliadora Aracil‐Fernández, Gabriel Rubio, Jorge Manzanares   +5 more
wiley   +1 more source

Life-skills training program: its effect on self-efficacy among patients with substance use disorders. [PDF]

BMC Psychol
Abdelmouttelb AA, Elewa SMM, Abdelsalhen FA, Ibrahim FM.   +3 more
europepmc   +1 more source